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Review
Anti-infectives are substances that in small 
doses can inhibit the growth or the survival 
of microorganisms without affecting the host 
(Foye et al. 1995; Korolkovas 1976). They 
comprise several classes of biologically active 
compounds of natural or seminatural origin 
such as antibiotics (e.g., β-lactams, tetra-
cyclines) or from synthetic sources such as 
antimicrobials (e.g., sulfonamides, quino-
lones) and some antifungals (e.g., azoles). 
These substances are used to treat infections 
or to prevent them in humans, animals, and 
food-producing insects and plants. In some 
food animals, subtherapeutic amounts of 
anti-infectives are also used as feed additives 
to reduce their susceptibility to stress-related 
diseases and to enhance growth (Kumar et al. 
2005). Anti-infectives have been recognized as 
the most significant therapeutic breakthrough 
in the history of medicine (Levy 1992), and 
estimates indicate that between 100 and 
200 × 106 kg of these compounds are con-
sumed annually worldwide (Wise 2002). 
The first report on the appearance of 
anti-infectives in the environment was pub-
lished in 1983 (Watts et al. 1983). Further 
studies were limited by the availability of 
sufficiently sensitive techniques, and it was 
not until the late 1990s and early 2000 that 
sensitive methods of trace analysis were first 
introduced (Golet et al. 2001; Hirsch et al. 
1998; Lindsey et al. 2001). The occurrence 
of these compounds in the environment has 
raised concern about their potential role in 
the dissemination of anti-infective resistance 
in bacteria and the impact of their biological 
activity on the health of aquatic ecosystems 
(Daughton and Ternes 1999).
To date, no comprehensive review on the 
occurrence of anti-infectives in the environ-
ment has been published. Therefore, the main 
goal of this work is 3-fold: a) to summarize 
published information on the environ  mental 
concentrations of anti-infectives in water 
matrices (wastewaters and natural and drink-
ing waters) in the last 24 years; b) to sum-
marize the present body of knowledge on 
the presence of anti-infectives in the aquatic 
environ  ment; and c) to estimate possible 
effects of anti-infectives in the environment 
by comparing environmental concentrations 
with environmental effective concentrations. 
Here we do not discuss fate and occur-
rence in soils or sediments, as other papers 
have already commented on this subject 
(Thiele-Bruhn 2003; Tolls 2001). Analytical 
methods (Díaz-Cruz and Barceló 2005; Fatta 
et al. 2007; Ternes 2001), the fate in waste-
water treatment plants (Jones et al. 2005; 
Petrović et al. 2003), and ecotoxicity (Crane 
et al. 2006; Jjemba 2006; Jones et al. 2004) 
are also among the subjects that will not be 
discussed in detail, given the excellent earlier 
published reviews.
Sources and transport. Several sources of 
anti-infectives in the environment have been 
identified, such as manufacturing wastes (Babić 
et al. 2007; Larsson et al. 2007), improper 
disposal of unused medication (Bound and 
Voulvoulis 2005), and landfill leachates (Holm 
et al. 1995). However, it has been recognized 
that the excretions of people or animals under 
treatment are the foremost source of anti- 
infectives in the aquatic environment (Hirsch 
et al. 1999). Hence, anti-infectives reach the 
aquatic environment through two main routes: 
urban and agricultural. 
In the urban route, the anti-infectives 
excreted [for some compounds, as much as 
90% in the parent form (Jjemba 2006)], 
washed off (in the case of topical formula-
tions), or discarded by people in households, 
hospitals, or industries will end up in sew-
age. Once in wastewater, anti-infectives 
are discharged directly to surface waters or 
transported by sewers to wastewater treat-
ment plants (WWTPs). During this pro-
cess, the anti-infective loads in sewage may 
be diluted by the mixing with used water 
containing none of these substances (Alexy 
2004). Anti-infectives may also reach the 
aquatic environment directly because of leak-
ing sewers and sewer overflows (Sedlak et al. 
2004). Compounds arriving at WWTPs may 
be eliminated from wastewater, depending 
mainly on their capacity to associate with 
particulate matter (which influences their 
removal by physicochemical or biological 
treatments) and their susceptibility to bio-
logical transformation (which certainly affects 
their elimination by biological treatment) 
(Ternes and Joss 2006). Partial biodegrada-
tion and mineralization of anti-infectives 
in WWTPs is possible, as bacteria may 
cometabo  lize these substances or use them as 
a source of carbon and energy to grow (Ternes 
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et al. 2004). Substances having a lower affi- 
nity for solids and higher resistance to 
biotransformation will be subsequently dis-
charged into streams (Roberts and Thomas 
2006). Substances sorbed to sludge during 
treatment in WWTPs can also reach the envi-
ronment by the application of sewage sludge 
in agricultural fields or by leaching in land-
fills. For these reasons, WWTPs are the main 
entry point of urban anti-infectives into the 
aquatic environment (Glassmeyer et al. 2008; 
Ternes et al. 2004)
In the agricultural route, anti-infectives 
present in animal excreta may reach the 
aquatic environment by drainage and runoff 
to surface water and by percolation to ground-
water. Studies have shown that compounds 
may be transported by the aqueous phase or 
bound to particulates in suspension (Kay et al. 
2004, 2005), and this pathway is enhanced 
mainly because of land application of manure 
(Alexy 2004; Kumar et al. 2005). Substances 
retained and progressively accumulated in 
soils can be gradually released into the aque-
ous phase; agricultural soils may therefore act 
as environmental reservoirs for anti-infectives 
(Lee et al. 2007; Rooklidge 2004). These sub-
stances can also reach natural waters directly 
by leaking from manure storage structures or 
constructed lagoons (Meyer 2004) or through 
dust (Hamscher et al. 2003). Compounds 
used in aquaculture are often released directly 
into surface waters by leaching from food pel-
lets, fish feces, or pond sediments (Cabello 
2006; Lee et al. 2007). Anti-infectives sprayed 
on fruit plants may reach the aquatic environ-
ment; however, this pathway has not yet been 
documented. Therefore, agricultural activi-
ties may be considered among the main non-
point sources of anti-infectives in the aquatic 
  environment.
Fate and effects. Once in the aquatic 
environment, anti-infectives are affected by 
different abiotic and biotic processes influ-
encing their bioavailability and their sub-
sequent impact on aquatic biota. The relative 
importance of these processes on the fate of 
anti-infectives is dictated by their physico-
chemical properties as well as by the condi-
tions of the medium in which they are present 
(Peschka et al. 2007). Biodegradation and   
nonbiological processes such as sorption, 
photo  lysis, and hydrolysis may reduce anti-
infective loads in the environment and result 
in partial degradation or mineralization 
of these compounds (Alexy 2004; Halling-
Sørensen et al. 1998). Compounds having 
a lower susceptibility to these processes may 
be persistent, in which case their environ-
mental concentrations are reduced mainly 
through dilution in the aquatic environment. 
However, anti-infectives do not need to be 
very persistent in the environment to be able 
to have an effect. Contrary to other organic 
pollutants such as pesticides (Comoretto and 
Chiron 2005), anti-infectives are constantly 
released in the environment; therefore, sub-
stances degrading in a few days can be consid-
ered persistent with respect to natural waters 
at the point of discharge where releases are 
continuous (Sedlak et al. 2004). 
Anti-infective resistance. To date, the 
main interest for the study of anti-infectives in 
the environment has focused on their potential 
role on the spread of anti-infective resistance, 
as these substances are specifically designed 
and used with the purpose of inhibiting 
microbes. Anti-infective resistance is defined 
as the ability of a population of microorganism 
cells to neutralize the toxic effect of an anti-
infective (Suling and O’Leary 1975). When 
a bacterium develops resistance to a particular 
anti-infective mode of action, either by the 
acquisition of genes via mobile agents (e.g., 
plasmids and transposons) or by means of 
mutations, it gains an evolutionary advantage 
over its nonresistant congeners when the host 
is under anti-infective treatment (Levy and 
Marshall 2004). However, this advantage ends 
once therapy on the patient is over, because 
the recolonization of the medium by non-
resistant bacteria will not be impeded and, as a 
consequence, resistant strains become diluted 
(Levy and Marshall 2004). 
So is it possible that anti-infective occur-
rence in environmental waters promotes 
resistance? Several authors have argued that 
if concentrations are higher than the mini-
mum inhibitory concentrations (MICs) of 
some pathogenic bacteria, a selective pressure 
would be exerted and, as a result, the dissemi-
nation of anti-infective resistance could be 
enhanced (Kümmerer and Henninger 2003). 
It has also been proven that even subinhibi-
tory concentrations (e.g., one-fourth of the 
MIC) of several anti-infectives are able to 
have an effect [e.g., as shown for the modula-
tion of the expression of toxin-encoding genes 
in Staphylococcus aureus (Ohlsen et al. 1998)]. 
Transfer of genetic elements among bacte-
ria has been observed under natural condi-
tions in WWTPs (Marcinek et al. 1998), and 
selection of resistant bacteria has been docu-
mented in sewers receiving wastewaters from 
pharmaceutical plants (Guardabassi et al. 
1998). Agricultural activities may also con-
tribute to the transfer of resistance genes from 
wastewater bacteria to indigenous soil micro-
biota (Chee-Sanford et al. 2001). However, 
the extent of the impact of the occurrence of 
anti-infectives in the aquatic environment on 
the dissemination of resistance in bacteria is 
still a subject of debate (Ohlsen et al. 2003; 
Summers 2002), and present knowledge 
indicates that its impact is still questionable 
(Kümmerer 2004). 
Ecosystem health. Anti-infectives are bio-
logically active substances; therefore, they pose 
a potential threat to aquatic biota. Recently, 
numerous studies have reported the acute 
and chronic toxic effects of anti-infectives on 
nontarget organisms such as diatoms (Wilson 
et al. 2003), algae (Ferrari et al. 2004; Halling-
Sørensen 2000), crustaceans (Ferrari et al. 
2004; Flaherty and Dodson 2005; Isidori et al. 
2005), rotifers (Ferrari et al. 2004; Isidori et al. 
2005), cnidarians (Quinn et al. 2008), and 
amphipods (Maul et al. 2006). These reports 
indicate that effective concentrations of most 
studied aquatic species are 2–5 orders of mag-
nitude higher than those generally found in 
contaminated natural waters. Nevertheless, 
sensitive species such as diatoms, green algae, 
cyanobacteria, and some pathogenic bac  teria 
(Al-Ahmad et al. 1999; Kümmerer et al. 2000; 
Wilson et al. 2003) are affected by concen-
trations < 2,000 ng/L. We must also con-
sider that most of these studies target effects 
using a single species and single compounds. 
Surface waters near WWTP outfalls contain a 
myriad of organic and inorganic compounds 
that can interact as toxic mixtures. In com-
parison to short-term exposures in the labora-
tory, chronic exposures are likely to result in 
observable effects at lower thresholds. Other 
changes in the environment, indirect effects 
or more subtle effects that may affect species 
such as food selection behavior (Daughton 
and Ternes 1999; Hahn and Schulz 2007), 
or the fate of other organic pollutants such as 
pesticides should also be contemplated (Boxall 
et al. 2003).
Methods
Selection and classification of literature data. 
Because an enormous amount of data has 
been published over the last 24 years on the 
occurrence of anti-infectives in the environ-
ment, we decided to set the following criteria 
to select and assure the quality of the compiled 
values. Only data reported in peer-reviewed 
journals written in the English language were 
considered for compilation. Only articles 
indicating or citing the limit of quantification 
(LOQ) of their determination method were 
selected. Therefore, only values higher than or 
equal to the reported LOQ were considered. 
When the authors reported only the limit of 
detection (LOD), the LOQ was evaluated by 
multi  plying the LOD by a conversion fac-
tor x according to the definition of the LOD 
used by the authors. For example, when the 
authors defined the LOD as the concentra-
tion giving a signal-to-noise ratio (S/N) of 
3, the LOQ was calculated by multiplying 
the LOD by a factor x = 3.3, as the LOQ is 
equivalent to S/N = 10. In addition, when the 
same substance was analyzed by more than 
one method in the same study, the concentra-
tion reported using the most sensitive method 
(lower LOQ) was used. When the authors did 
not report any concentrations in real samples, Anti-infectives in contaminated wastewaters and natural and drinking waters 
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their LOQ values were selected for compila-
tion. Only concentrations in which the type 
(e.g., raw sewage, surface water) and the coun-
try of provenance of the sample were clearly 
indicated were used. Only data reported as 
numeric values were used. Data reported in 
figures were not considered because of the 
uncertainty of their interpretation. Only natu-
ral concentrations were reported; values in 
natural waters with experimental amendment 
of manure or sediments were not considered. 
Urban effluents were classified in three cate-
gories according to the treatment applied: 
primary (physical or mechanical), second-
ary (biological), and tertiary (advanced, such 
as disinfection by chlorination or ultraviolet 
radia  tion) (vanLoon and Duffy 2000). Waters 
found in agricultural matrices such as runoff, 
lagoons, and field streams were classified as 
wastewaters.Ecotoxicologic data such as low-
est observed effective concentration (LOEC) 
and 50% effective concentration (EC50) of 
sulfamethoxa  zole and ofloxacin for several 
types of bacteria and aquatic species were 
gathered from the peer-reviewed literature. 
We included as many different species as pos-
sible to illustrate the distribution of effective 
concentrations on aquatic biota of these two 
anti-infectives. 
Statistical analysis. The distribution of anti-
infective concentrations in the different matri-
ces are described by their arithmetic mean, 
median, 75th and 95th percentiles, and maxi-
mal concentrations. We mined the data look-
ing for expected trends or for possible relations 
with factors such as the geographic region, 
anti-infective class, and the treatment process, 
if any. The matrix of selected data cannot be 
processed entirely through statistical analyses 
because of the heterogeneity of the studied 
compounds between matrices and countries. 
However, focusing on urban wastewater and 
on three data-rich classes (macro  lides, quino-
lones, sulfonamides) and one compound 
(trimethoprim), we compared their concen-
trations in raw and treated wastewaters from 
three different regions (East Asia, Europe, and 
North America). An analysis of variance with 
the general linear model procedures of SPSS 
(version 16.0; SPSS Inc., Chicago, IL, USA) 
was used for that purpose. Density histograms 
and normal density functions of sulfamethox-
azole, ofloxacin, and their LOEC and EC50 
were calculated by Systat (version 11.0; Systat 
Software Inc., Chicago, IL, USA). 
Results and Discussion
Occurrence of anti-infectives in the environ-
ment. A bibliographic search of the scien-
tific literature found 159 articles published 
between 1984 and mid-2008 reporting analy-
ses of anti-infectives in wastewaters, surface 
waters, or drinking waters. The attention that 
the occurrence of anti-infectives in the aquatic 
environment has generated in recent years is 
reflected by the number of papers published 
each 5-year period since 1984: 2 (1984–1988), 
0 (1989–1993), 6 (1994–1998), 27 (1999–
2003), and 124 (2004–2008). Most of the 
studies we found reported concentrations of 
these compounds in environmental waters 
coming from countries defined as having high 
incomes (World Bank 2008); in fact, only 28 
articles of 159 originally found (18%) analyzed 
waters from low- to middle-income countries. 
Applying the selection criteria enumerated 
in the “Methods,” we eliminated 16 articles. A 
database was built containing > 2,200 values 
of concentrations and 2,500 LOQ values of 
anti-infectives in drinking, natural, and waste-
waters reported in the 143 selected publica-
tions. A summary of the detection instruments 
showed than 75% of the reported values come 
from methods using tandem mass spectrom-
etry, 14% from single mass spectrometry, and 
11% from molecular spectroscopy (fluores-
cence or ultraviolet). By compiling the data 
obtained from different analytical methods 
and sources, we tried to offset a bias in our 
results caused by the publications reporting 
more values. In total, from the 126 different 
substances (parent compounds, degradation 
products, or metabolites) for which at least 
one method of determination exists, only 
68 different parent compounds and 10 deg-
radation products or metabolites have been 
quantified so far in environmental waters. 
Table 1 shows occurrence data sets orga-
nized by anti-infective class and matrix. For 
more detailed information, see Supplemental 
Material, Table 1 (available online at http://
www.ehponline.org/members/2009/11776/
suppl.pdf). 
Several classes of anti-infectives have been 
less frequently reported in spite of the numer-
ous studies that have tried to determine them. 
One example is the β-lactams, for which only 
12 of 24 different compounds have been deter-
mined so far in environmental waters. As men-
tioned earlier, this is due to their high reactivity 
in aquatic media. Also, among the most impor-
tant classes of anti-infectives that have not yet 
been determined are the quinoxaline dioxides 
(carbadox, olaquindox), which at least 13 dif-
ferent studies have been unable to quantitate. 
The study of metabolites is impor-
tant for the accurate determination of anti- 
infectives, as some conjugated metabolites, 
such as glucuronide, sulfate, and N-acetyl, can 
be deconjugated in wastewaters by bacterial 
enzymes, thus increasing the concentration 
of the parent drug (Jones et al. 2005). Few 
studies have looked into this problem, and 
only N4-acetylsulfamethoxazole, a metabo-
lite of the sulfonamide sulfamethoxazole, has 
been quantitated to date (Ashton et al. 2004; 
Göbel et al. 2004, 2005, 2007; Hilton and 
Thomas 2003). As for degradation products, 
their occurrence is less significant in the 
environment if they are not as biologically 
active as the parent drug. This is the case of 
anhydro-erythromycin (erythromycin-H2O), 
the degradation product of the macrolide 
erythromycin, which has been widely quan-
titated in the literature. Other degradation 
products such as those of the β-lactams or the 
tetracyclines have been only sparsely docu-
mented (Li et al. 2008b; Mackie et al. 2006).
An important aspect of our study that we 
must emphasize is that the selected occurrence 
data are not representative of the water matri-
ces or the global state of water contamination 
with respect to anti-infectives. Published values 
are biased, because analyzed samples are often 
collected in sites where contamination is sus-
pected. In addition, information on frequency 
of detection is not always available, which also 
overestimates the occurrence of anti-infec-
tives. Therefore, it must be kept in mind that 
throughout our study, our results and conclu-
sions apply mostly to contaminated waters. 
Drinking water. Occurrence of anti-
infectives in drinking water is the least 
reported so far. Only about 2% (3 of 143 
selected papers) indicate quantitative values 
in drinking water, even though more than 
eight different studies have tried to meas  ure 
them. This can be explained by the low limits 
of quantification necessary to achieve their 
determination in drinking water, which often 
must be < 1 ng/L. Anti-infective concentra-
tions in contaminated tap water range from 
0.3 to 5 ng/L, with a median concentration 
of 2 ng/L. We found only one study that 
attempted to measure the concentration of 
degradation products or metabolites. Anti-
infectives reach drinking water, albeit in very 
low amounts, because they are able to persist 
in natural water sources and resist purification 
processes in drinking water treatment plants 
(DWTPs). However, anti-infectives seem to 
be more affected by purification processes 
than other, more frequently reported organic 
wastewater contaminants (OWCs). In a study 
on the fate of 106 OWCs (including 25 anti- 
infectives) in a conventional DWTP using 
several physico  chemical processes in sequence, 
from the 42 OWCs detected above their 
reporting limit in stream and raw water sam-
ples, only five were anti-infectives. In finished 
waters, only 17 OWCs were detected, and 
none of them were anti-infectives (Stackelberg 
et al. 2004). A study on the effectiveness of 
several treatment processes used in DWTPs 
showed that activated carbon sorption, reverse 
osmosis, and oxidation (chlorination or ozo-
nation) were among the most efficient treat-
ments to remove anti-infectives from source 
water (Adams et al. 2002). 
Natural waters. Occurrence of anti-
  infectives has been well documented in both 
groundwater and surface waters (44% of Segura et al.
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selected articles). Rivers, creeks, lakes, estuar-
ies, basins, sea waters, and wells have been 
reported to be contaminated by several of 
these compounds. Values found in the lit-
erature show up to eight orders of magni-
tude of variation, and concentrations often 
decrease as the distance from the source 
(WWTP outfalls, landfills, etc.) increases. The 
cause of the attenuation of anti-infectives in 
surface waters cannot be easily interpreted, 
because different attenuation mechanisms 
may operate simultaneously (Sedlak et al. 
2004). Published data in the literature do not 
indicate the present state of the global anti- 
infective contamination of surface waters, and 
this may appear overestimated by the choice 
of sampling points, often near WWTP out-
falls or agricultural areas. For example, a study 
of 139 streams in the United States showed 
that only 2 of the 23 targeted anti-infectives 
were detected in > 20% of the samples col-
lected in zones susceptible of contamination 
(Kolpin et al. 2002). These observations were 
later confirmed by Focazio et al. (2008), who 
showed that only 6 anti-infectives from the 
25 initially targeted were found in < 35% of 
the 74 untreated drinking water sources across 
the United States. 
Surface waters. As the receptors of most 
WWTP final effluents, outfalls in streams and 
the nearby downstream zones act as collectors 
of all the substances that were not removed by 
the treatment process. Our database showed 
Table 1. Occurrence in nanograms per liter of anti-infectives in contaminated wastewaters and natural and drinking waters organized by class and matrix.
Anti-infective class   No. > LOQa  No. papersb  Mean  Median  75%  95%  Max  LOQlow
c  LOQhigh
d
Wastewaters
As parent compounds 
Azoles  17  6  5,987  26  50  61,920  90,200  5  112
β-Lactams  42  15  4,633  300  1,200  5,360  153,000  1  100,000
Quinolaxine-dioxide  0  5            5  100
Lincosamides  33  10  18,715  60  2,125  190,500  240,000  0.3  100
Macrolides  217  43  352  110  271  1,000  27,000  0.2  1,155
Poliether ionophores  13  2  29  11  26  167  190  1  3
Quinolones  420  51  152,247  205  570  41,922  31,000,000  1  20,600
Sulfonamides  289  57  11,972  330  800  31,000  1,158,680  1  300,000
Tetracyclines  161  32  11,642,200  530  7,250  6,095,000  920,000,000  1  700,000
Trimethoprime  210  52  1,351  270  795  5,000  55,200  1  150,000
Other  17  11  750  39  1,115  4,101  5,000  3  667
As metabolites/degradation products 
β-Lactams  10  1  55,794,600  7,630,000  44,500,000  389,000,000  389,000,000  410  1,360
Macrolides  52  16  2,848  450  1,414  5,650  83,000  1  500
Sulfonamides  13  5  779  570  1,200  2,230  2,235  20  212
Tetracyclines  6  1  5,092,167  1,445,000  9,420,000  18,100,000  18,100,000  600  1,300
Natural waters
As parent compounds 
Azoles  39  11  18  18  23  44  58  1  370
β-Lactams  6  16  73  11  48  350  350  2  24,000
Quinolaxine-dioxide  0  9            35  1,400
Lincosamides  46  21  147  18  100  1,020  1,400  0.04  198
Macrolides  128  38  58  11  46  197  1,022  0.02  1,155
Poliether ionophores  4  4  312  35  606  1,172  1,172  0.1  380
Quinolones  78  31  199  27  108  640  5,600  0.3  7,000
Sulfonamides  234  60  66,531  120  700  472,000  1,600,000  0.2  33,000
Tetracyclines  47  33  97,369  192  658  623,550  712,000  0.07  1,650
Trimethoprim  90  24  94  18  42  510  3,000  0.2  4,000
Other  5  21  136  127  207  266  266  2  2,000
As metabolites/degradation products 
β-Lactams  4  1  4,719,500  4,037,500  8,840,000  10,540,000  10,540,000  410  1,360
Macrolides  51  24  184  40  146  1,186  1,700  0.3  250
Sulfonamides  6  6  86  14  239  240  240  2  50
Tetracyclines  27  25  12,367  11,100  14,750  32,840  34,200  10  1,300
Drinking waters
As parent compounds 
Azoles  0  1            370  370
β-Lactams  0  0            NA  NA
Quinolaxine-dioxide  0  1            100  100
Lincosamides  0  2            0.07  5
Macrolides  4  2  3  3  5  5  5  0.07  220
Poliether ionophores  0  0            NA  NA
Quinolones  5  2  2  2  3  4  4  0.3  10
Sulfonamides  2  5  0.4  0.4  0.5  0.5  0.5  0.2  1,155
Tetracyclines  0  1            3  12
Trimethoprim  0  4            0.5  250
Other  0  1            5  5
As metabolites/degradation products 
β-Lactams  0  0            NA  NA
Macrolides  0  1            10  10
Sulfonamides  0  0            NA  NA
Tetracyclines  0  0            NA  NA
NA, not available.
aNumber of values reported as being > LOQ for each class. bNumber of papers reporting analysis in each matrix for each class. cLowest LOQ reported. dHighest LOQ reported. eDihydro-
folate reductase inhibitor. Anti-infectives in contaminated wastewaters and natural and drinking waters 
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that 52 of 143 papers (36%) report concen-
trations of anti-infectives in surface waters. 
Median concentration of these drugs in con-
taminated surface waters was 30 ng/L, and 
values varied between 0.07 and 712,000 ng/L. 
As for metabolites and degradation products, 
their median concentration was 548 ng/L, and 
reported amounts ranged from 2–10,540,000 
ng/L. Detection of anti-infectives in surface 
waters upstream of WWTPs outfalls indicate 
the persistence and mobility of these com-
pounds, which may be discharged by point 
or nonpoint sources. The importance of these 
sources on the anti-infective occurrence in 
downstream surface water depends clearly 
on the season and hydrology of the region. 
Kolpin et al. ( 2004) demonstrated that stream 
flow conditions significantly affect occur-
rence of organic wastewater contaminants, 
as higher flows increase the dilution factor of 
WWTP effluents. Also, the contribution of 
WWTP effluents to the total flow of rivers 
is determinant. Rivers in which the majority 
of the flow is composed of WWTP effluent 
will have a lower diluting power (some rivers 
are composed of up to 75–80% of WWTP 
discharges), and anti-infective concentrations 
downstream will be approximately constant, 
depending on other attenuation processes such 
as photolysis or sorption (Bendz et al. 2005; 
Hirsch et al. 1999). 
Groundwaters. Groundwaters are affected 
by a variety of sources, with landfills, sep-
tic systems, and agricultural fields represent-
ing the most significant potential sources 
of anti-infective contamination. A recent 
national reconnaissance study of 65 OWCs 
in groundwaters in the United States (Barnes 
et al. 2008) detected only 3 anti-infectives 
of the 21 targeted. Sulfamethoxazole was the 
most frequently detected (23.4%), and its 
maximum concentration was 1,110 ng/L. 
However, the detected anti-infectives repre-
sented < 5% of the total OWCs concentra-
tion. According to our database, 10% (13 of 
143 sampled articles) reported concentrations 
of anti-infectives in groundwaters in the range 
of 0.2–1,400 ng/L, and a median concentra-
tion of 71 ng/L. Only one paper, a study on 
the occurrence of sulfonamides in ground-
waters near a pharmaceutical waste landfill 
in Denmark (Holm et al. 1995), reported 
higher amounts, with a median concentration 
of 190,000 ng/L and a maximum concen-
tration as high as 1,600,000 ng/L. Landfills 
containing WWTP biosolids or discarded 
anti-infectives contaminate groundwaters 
because leachate plumes may reach nearby 
aquifers. In addition, as opposed to surface 
waters, anaerobic or suboxic conditions are 
often observed in groundwaters and may pre-
vent or slow down the degradation rates of 
some anti-infectives (Verstraeten et al. 2005). 
Studies on the disposal of pharmaceuticals in 
the United States and the United Kingdom 
(Bound and Voulvoulis 2005; Kuspis and 
Krenzelok 1996) showed that a significant 
proportion of people (54% in the United 
States, 71% in the United Kingdom) disposed 
of unused medication in the trash. Hence, 
the role of landfills in the contamination of 
groundwaters should be reassessed, as disposal 
of anti-infectives is usually considered only a 
minor source of contamination (Boxall 2004). 
Wastewaters. Wastewaters produced 
by urban centers as well as by agricultural 
activities were the most studied matrices in 
the selected literature (62%). Reported con-
centrations in this matrix are obviously the 
highest, but they vary by up to 10 orders of 
magnitude. This huge variability is mainly a 
consequence of the diverse origin of the waste-
waters, which may come from industries, hos-
pitals, municipal WWTPs, farm lagoons, field 
runoff, and so on. Also, anti-infective concen-
trations are affected by the different treatment 
process applied to wastewaters, which in some 
cases are nonexistent (as is the case of direct 
discharges of urban or agricultural origin) 
and in others very advanced, such as tertiary 
wastewater treatment systems that include 
reverse osmosis and micro- and nano  filtration 
as well as ozonation. 
Industrial sewage. Manufacture of anti-
infectives often generates highly contaminated 
sewage. For example, biosynthetic fabrica-
tion of tetracyclines produces wastes having 
high chemical oxygen demand (COD) loads, 
and treatment of these waters is both difficult 
and expensive (Li et al. 2004). Consequently, 
anti-infective concentrations in these manu-
facturing wastes are worryingly high, as is the 
case of wastewaters from oxytetracycline pro-
duction facilities reaching values as high as 
920,000,000 ng/L (Li et al. 2008a), which are 
several times higher than the EC50 for some 
aquatic species such as Microcystis aeruginosa 
(EC50 = 20,700 ng/L) or Rhodomonas salina 
(EC50 = 160,000 ng/L) (Holten-Lützhøft 
et al. 1999). Other compounds such as the 
quinolones have also been reported in efflu-
ents from drug manufacturers (Larsson et al. 
2007) with concentrations of ciprofloxacin 
up to 30,000,000 ng/L, which are well above 
EC50 values for several aquatic species as well 
(Larsson et al. 2007). The mixing of indus-
trial wastes with human sewage creates fur-
ther concerns because it generates an ideal 
environ  ment for spreading anti-infective resis-
tance in bacteria (Larsson et al. 2007). The 
β-lactams and their metabolites have been 
also reported in manufacturing plant efflu-
ents, with a concentration of benzyl  penicillin 
(153,000 ng/L) comparable to published 
MICs (Li et al. 2008b).
According to our bibliographic research, 
about 5% (7 of 143 of the sampled articles) 
report the presence of anti-infectives in 
industrial wastewaters and concentrations 
range from 4,900–920,000,000 ng/L, with a 
median concentration of 300,000 ng/L. The 
extent of the contribution coming from man-
ufacturing plants to the overall occurrence 
of anti-infectives in the environment cannot 
be evaluated at present, because published 
data are still scarce. (These reports were lim-
ited to only three countries: China, India, 
and Croatia). Industrial discharges in the 
environment in high-income countries like 
the United States are controlled by current 
good manufacturing practices and emissions 
regu  la  tions (Velagaleti et al. 2002); therefore, 
the impact of drug manufacturers should be 
limited only to countries with more flexible 
legis  lation (or lacking the resources to enforce 
them). In 1999, low- to middle-income coun-
tries accounted for only 7.1% (by value) of 
the world pharmaceutical production; never-
the  less, at least 10 low- to middle-income 
countries produce active ingredients, with 
China and India leading this group (World 
Health Organization 2004). In countries with 
less strict regulations, anti-infective produc-
tion facilities may be among the most impor-
tant sources of these substances in their nearby 
aquatic environment (Larsson et al. 2007).
Hospital sewage. Hospitals are consid-
ered one of the most important sources of 
anti-infectives in the aquatic environment 
(Gómez et al. 2006). However, < 8% of the 
selected papers (12 of 143) report the occur-
rence of these compounds in hospital sewage. 
Concentrations of anti-infectives in contami-
nated hospital waters range from 10–124,500 
ng/L, with a median value of 2,100 ng/L. 
The maximum concentration of ciprofloxa-
cin found in hospital effluents (124,500 
ng/L) (Hartmann et al. 1988) is considerably 
higher than the lowest effect concentration 
of ciprofloxacin for genotoxicty (LOEC = 
200 ng/L) or the EC50 of some pathogens 
(EC50 = 2000 ng/L) (Kümmerer et al. 2000). 
Quinolones, especially ciprofloxacin, were 
the main cause of the DNA-damaging effects 
detected in wastewater samples from hospi-
tals (Hartmann et al. 1988). Additionally, 
compared with antineoplastic drugs, quino-
lones have a greater potential to cause DNA 
damage (Hartmann 1999). These findings 
support the concern for the potential impact 
of anti-infective residues on the spread of bac-
terial resistance, although according to other 
studies, the concentrations of anti-infectives 
found in hospital waste  waters are below the 
concentrations known to promote resistance 
(Jarnheimer et al. 2004; Ohlsen et al. 2003). 
Although detection frequencies and con-
centrations are generally higher in hospital sew-
age than in municipal wastewaters, it has also 
been reported that anti-infective concentrations 
in hospital sewage are similar or lower than the 
concentrations found in municipal WWTP Segura et al.
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influents (Karthikeyan and Meyer 2006) 
or retirement homes (Brown et al. 2006). 
Therefore, the impact of hospitals may depend 
on the communities, the season, and water use, 
but results tend to indicate that wherever large 
groups of individuals under medication cohabit 
in the same location, significant concentrations 
of anti-infectives will be found in sewage. 
Agricultural and aquacultural waste-
waters. Papers reporting the presence of anti-
infectives in agricultural waters coming from 
hog, fish, and shrimp breeding are among the 
first reports published in the anti-infectives 
in the environment literature (Migliore et al. 
1996; Smith et al. 1994). These studies reflect 
early concerns on the intense use of these com-
pounds in farming and their fate. About 7% of 
the selected articles (10 of 143) report values 
in agricultural wastewaters. Concentrations 
of anti-infectives in lagoons or aquaculture 
ponds range between 1 and 13,000,000 ng/L, 
with a median concentration of 22,930 ng/L. 
Residues of these drugs in aquaculture waters 
may reach high values because they are used as 
feed additives; they may leach from the food 
pellets and are also excreted by the animals. 
Sediments may also accumulate anti-infectives, 
which may be released later in the water. 
Estimates indicate that 70–80% of drugs used 
as feed in aquaculture may reach the environ-
ment (Holten-Lützhøft et al. 1999; Migliore 
et al. 1996). 
Occurrence of anti-infectives in field tiles, 
field streams, and runoff show much lower 
concentrations (2–4,000 ng/L). Differences 
in concentrations for anti-infectives in these 
matrices may be due to several factors such 
as the dose used, resistance to biodegrada-
tion, and mobility, as well as soil characteris-
tics. Because the mobility of anti-infectives is 
affected by their affinity to particulate mat-
ter, their occurrence in overland flow seems 
to be more important for rather hydro-
philic compounds such as the sulfonamides 
or trimethoprim than more hydrophobic or 
binding-capable compounds such as the tetra-
cyclines or the macrolides (Kay et al. 2004). 
However, compounds having high sorption 
coefficients are still able to be transported and 
reach environmental waters (Kay et al. 2004). 
Sorption of more hydrophilic compounds 
(e.g., sulfonamides) onto soils may increase 
with time, thus reducing their release into 
environmental waters (Stoob et al. 2007). The 
influence of other transport process such as 
binding to dissolved organic matter remains 
unclear (Lee et al. 2007). 
Urban wastewaters. Because of the 
preponderant role of WWTPs on the anti- 
infective contamination of surface waters, 
urban wastewaters have been extensively stud-
ied in the past 10 years. In fact, 51% of the 
sampled papers reported concentrations in 
urban wastewaters. In our database, occurrence 
of anti-infectives in urban raw sewage range 
from 3–10,570 ng/L, with a median concen-
tration of 300 ng/L. In treated effluents, con-
centrations vary between 1 and 29,000 ng/L 
and a median of 136 ng/L. Analyses in raw 
sewage and WWTP effluents applying dif-
ferent types of processes have demonstrated 
the failure of the commonly used wastewater 
treatment technologies to completely remove 
anti-infectives present in wastewaters. 
As our bibliographic research of urban 
wastewaters provides enough data for three 
classes of substances [macrolides (including 
anhydro-erythromycin, the degradation prod-
uct of erythromycin), quinolones, and sulfon-
amides] and one compound (trimethoprim), 
four levels of treatment (none, primary, second-
ary, and tertiary) in three geographic areas: East 
Asia (China, Japan, and South Korea), Europe 
(Austria, Croatia, Denmark, France, Finland, 
Germany, Greece, Italy, Norway, Sweden, 
Spain, Switzerland, and the United Kingdom), 
and North America (Canada, Mexico, and the 
United States), it was possible to investigate the 
influence of these factors on anti-infective con-
centrations. Analysis of variance with Dunnet’s 
T3 post-hoc tests showed significantly higher 
(p < 0.05) concentrations in raw wastewaters 
compared with primary, secondary, and ter-
tiary effluents. Analysis of variance also showed 
that the concentrations measured in North 
America and East Asia were significantly higher 
than those in Europe. Furthermore, resulting 
concentrations of sulfonamides and trimethop-
rim are significantly higher than those of mac-
rolides and quinolones. These results confirm 
previous observations about the removal of 
anti-infectives in WWTPs (Batt et al. 2007; 
Göbel et al. 2005; Gulkowska et al. 2008; 
Ternes et al. 2004). Removal efficiency is 
dependent on many factors, the most impor-
tant being the type of treatment (e.g., primary, 
secondary), the WWTP design (hydraulic and 
solid retention times, sludge age, etc.), and the 
physico  chemical properties of each compound 
(e.g., pKa and log Dow).
Ecologic significance of ambient concen-
trations of anti-infectives. The case of sulfa-
methoxazole and ofloxacin. Sulfamethoxazole 
and ofloxacin were chosen for further insight 
into the significance of the occurrence data 
reported in the literature from an eco-
toxicologic standpoint. Figure 1 shows the 
histo  gram and the normal density function 
Figure 1. Density histogram (bars) and density function (line) of sulfamethoxazole occurence in natural 
waters (A) and wastewaters (B) compared with density histogram and density function of LOEC (left) and 
EC50 (right) values for several aquatic species exposed to sulfamethoxazole. 
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of sulfamethoxazole for natural and waste-
waters and the LOEC and EC50 for different 
species [see Supplemental Material, Table 2 
(available online at http://www.ehponline.org/
members/2009/11776/suppl.pdf)]. The distri-
bution of sulfa  methoxazole concentration in 
natural waters clusters around 102 ng/L, and 
for wastewaters this value is about an order of 
magnitude higher. This difference coincides 
well with fate data, showing a rather weak 
affinity of sulfamethoxazole for solids, which 
enhances its transport in the aqueous phase. 
Ecotoxicologic values show a much wider dis-
tribution, with a density function maximum 
around 106 ng/L for LOEC and 107 ng/L for 
EC50. In some cases, these density curves lie 
over common ranges, and we interpreted this 
overlapping as an increased risk for aquatic 
species. We observed that < 1% of LOEC 
values and < 0.1% of the EC50 values were 
lower than the highest 10% of the concentra-
tions of sulfamethoxazole in natural water. 
When looking at the density curves of effec-
tive concentrations versus occurrence of sulfa-
methoxazole in wastewaters, we can see that 
overlapping between them is slightly more 
important. About 3% of LOEC and < 1% of 
EC50 values were lower than the highest 10% 
of the concentrations of sulfamethoxazole in 
wastewaters. The presence of this overlapping 
region suggests that the observed concentra-
tions of sulfamethoxazole in natural waters are 
not high enough to affect most studied aquatic 
species but that concentrations in wastewaters 
could have in impact on the most sensitive 
species such as bacteria. 
In the case of ofloxacin (Figure 2), the 
distribution of its concentration shows that 
occurrence of this quinolone in natural waters 
centers around 102 ng/L, whereas in waste-
waters this value is between 1 and 2 orders 
of magnitude higher. Compared with sulfa-
methoxazole, this difference is more pro-
nounced, which is not surprising given the 
higher affinity of ofloxacin for solids and 
its subsequent better elimination by waste-
water treatments. As with sulfamethoxazole, 
ecotoxicologic values [see Supplemental 
Material, Table 3 (available online at http://
www.ehponline.org/members/2009/11776/
suppl.pdf)] show a wide distribution, having 
a maximum close to 105 ng/L for LOEC and 
106 ng/L for EC50. Less than 1% of LOEC 
values and < 0.1% of the EC50 density curves 
were lower than the highest 10% of concen-
trations of ofloxacin in natural water. Also, 
the density curve overlapping of wastewaters 
and effective concentrations is much more 
important than in the case of sulfamethoxa-
zole, with around 8% of LOEC values and 
< 2% of the EC50 values being lower than the 
highest 10% of concentrations of ofloxacin 
in wastewaters. Therefore, ofloxacin seems 
to present a higher ecotoxicologic risk than 
sulfamethoxazole, and detrimental effects on 
wastewater bacteria are more likely to occur 
than in aquatic biota.
Thus, what is the ecotoxicologic signifi-
cance of the occurrence of anti-infectives in 
environmental waters? Assuming that our 
sampled data are representative of ambient 
anti-infective concentrations in most contam-
inated environmental waters, it can be argued 
that even a weak overlapping between con-
centration values corresponding to environ-
mental waters and ecotoxicologic data could 
have detrimental effects on the most sensitive 
species such as bacteria or algae. In the case of 
surface waters, because anti-infectives are con-
stantly being released into the environment, 
microbiota are constantly exposed to these 
compounds. These harmful effects should be 
more important in small streams affected by 
urban or agricultural discharges, because of 
their reduced dilution capacity. With regard 
to wastewaters, even if our results show that 
high concentrations (> 10,000 ng/L) of 
anti-infectives in these waters are more the 
exception than the rule, the existence of a 
few locations where these concentrations can 
be reached are enough to contribute to the 
global spreading of anti-infective resistance 
(Okeke and Edelman 2001). Given that large 
populations of bacteria are being exposed to 
a selective pressure, environmental waters 
and especially wastewaters become ideal set-
tings for the assembly and exchange of mobile 
genetic agents encoding for resistance in bac-
teria (O’Brien 2002). 
Additional factors to be considered. 
Mixture effects. Mixture effects are expected 
in environmental waters because many other 
organic and inorganic contaminants are dis-
charged in conjunction with different anti-
infectives. According to a recent study using 
predicted environmental concentrations, when 
strong synergistic effects are present between 
anti-infectives and other pharmaceuticals 
occurring in wastewater, an impact on resis-
tance in bacteria is possible but not in fungi 
(Kostich and Lazorchak 2008). Certain sub-
stances that may be present in environmental 
waters have a synergistic effect on some anti-
infectives. For example the MIC of ampicillin 
for Pseudomonas aureginosa is 1,500 mg/L, but 
in combination with 500 mg/L EDTA, the 
MIC was reduced to 22 mg/L (Lambert et al. 
2004). Surfactants have also been reported as 
Figure 2. Density histogram (bars) and density function (line) of ofloxacin occurrence in natural waters (A) 
and wastewaters (B) compared with density histogram and density function of LOEC (left) and EC50 (right) 
values for several aqualtic species exposed to ofloxacin. 
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potentiators (agents capable of enhancing the 
activity of a substance) of chlor  tetracycline 
and benzyl  penicillin in certain bacterial 
strains (Suling and O’Leary 1975). In con-
trast, antago  nistic interactions between anti- 
infectives and other pharmaceuticals on 
Escherichia coli and human ovarian carcinoma 
cells have been observed in vitro with environ-
mentally realistic concentrations (Pomati et al. 
2008). Thus, more information is necessary to 
better predict the effect of chronic exposure to 
complex mixtures such as surface waters near 
WWTP outfalls.
Occurrence of anti-infectives in low- to 
middle-income countries. Our bibliographic 
research showed an important gap in the pres-
ent knowledge of anti-infective contamination 
on a global scale with regard to low- to middle- 
income countries. From the total 159 arti-
cles identified, 84% analyzed environmental 
waters in high-income countries; the remain-
ing 16% are from four Asian countries (China, 
India, Malaysia, and Vietnam), two European 
countries (Croatia and Poland), and one Latin 
American country (Mexico). We did not find 
any data in the peer-reviewed literature con-
cerning the environmental occurrence of anti-
infectives in Africa or in other Asian or Latin 
American countries. In 1999, low- and middle- 
income countries consumed < 10% (by value) 
of the world’s medicines (World Health 
Organization 2004). Nevertheless, the high 
rates of over-the-counter self-medication 
(Kamat and Nichter 1998; Kunin 1993) and 
wide availability of inexpensive anti-infectives 
combined with a lower access to public sewage 
networks could result in environmental waters 
containing significantly higher amounts of 
anti-infectives in these countries than in high-
income countries. Therefore, more research 
focusing on the occurrence of these substances 
in low- and middle-income countries is neces-
sary to properly evaluate the state and impact 
of global contamination of waters. In addition, 
discharge from anti-infective manufacturing in 
low- to middle-income countries needs to be 
studied, as their input could actually be the 
most important point source in the local envi-
ronment of some regions (Larsson et al. 2007). 
If anti-infective occurrence in environmental 
waters does promote resistance in bacteria, the 
contamination caused by anti-infectives should 
be approached from a global perspective, as 
people and products affected by these waters 
can contribute to the spread of anti-infective 
resistance to other parts of the world (O’Brien 
2002; Okeke and Edelman 2001).
Conclusion
Anti-infectives, the miracle drugs of the 
20th century, have become environmental 
contami  nants of emerging concern in the 
21st century. Research has shown that these 
compounds are persistent and mobile enough 
to be transported from landfills, agricultural 
fields, and urban centers to natural waters. 
To gain a better insight of the global con-
tamination caused by anti-infectives in envi-
ronmental waters, we created a database with 
more than 2,200 concentration values of 68 
parent drugs and 10 metabolites or degrada-
tion products reported in 143 peer-reviewed 
papers. Statistical analysis of concentrations 
of three classes of anti-infectives (macrolides, 
quino  lones, and sulfonamides) and trimetho-
prim in urban wastewaters in three geographic 
areas (East Asia, Europe, and North America) 
confirmed significantly higher concentrations 
in raw wastewaters compared with treated 
wastewaters. Also, concentrations measured in 
Europe were significantly lower than those in 
North America and East Asia. Furthermore, 
resulting concentrations of sulfonamides and 
trimethoprim are significantly higher than 
those of macrolides and quinolones. These 
results confirm previous observations about 
the factors influencing the removal of anti-
infectives. Comparison between sulfa  methoxa-
zole and ofloxacin occurrence in natural and 
wastewater and their effective concentrations 
in aquatic biota showed that there is a weak 
overlapping of the distribution curves and 
that only highly contaminated waters could 
affect the most sensitive species. However, 
potential effects on aquatic microbiota cannot 
be ruled out for the following reasons: 
•	Effects	of	chronic	exposure	of	sensitive	
organisms such as bacteria or algae to sub-
inhibitory concentrations of anti-infectives 
over long periods of time are still unknown. 
•	Even	if	highly	contaminated	wastewaters	are	
rather rare with respect to anti-infectives, 
heavily impacted industrial or agricultural 
wastewaters could become a nonnegligible 
environmental reservoir of anti-infective 
resistant bacteria, given that they have all 
the necessary elements of an ideal setting 
for the assembly and exchange of mobile 
genetic agents encoding for resistance. 
•	Current	knowledge	on	the	global	occurrence	
of anti-infectives in environmental waters is 
far from complete. More research is neces-
sary, especially for low- to middle-income 
countries, which may be more impacted 
by anti-infective contamination than high-
income countries because of less extended 
public sewage infrastructures, higher rates of 
self-prescription, and often less-strict indus-
trial emissions legislations. 
•	The	effects	of	cumulative	and	synergistic	
effects of anti-infectives in complex mixtures 
such as wastewaters are yet to be unraveled.
The current tendency toward larger and 
more densely populated production facili-
ties, such as concentrated animal feeding 
operations, suggests that occurrence of anti-
infectives in agricultural wastewaters may 
increase in the near future (Lee et al. 2007). 
Also, water-saving policies in urban settings 
would result in a reduction of wastewater 
volumes and consequently, in the increase 
of anti-infective levels because of lower dilu-
tion (Kümmerer 2004). Many measures to 
avoid the presence of pharmaceuticals in the 
environment have been proposed so far. Two 
main approaches in urban settings can be dis-
tinguished: source control and improvement 
of wastewater technologies. Source control 
solutions look for the reduction of pharma-
ceutical inputs before they reach public sewer 
systems, at the consumer level (e.g., environ-
mental labeling to inform patients and physi-
cians) or at the waste management level [e.g., 
urine separation (Larsen et al. 2004)], as well 
as pretreatment of hospital sewage (Ternes 
et al. 2004). Improvement of sewage treat-
ment processes to increase removal efficacy 
of WWTPs includes optimization of cur-
rent technology and the implementation of 
more advanced treatment techniques such 
as ozonation, advanced oxidation processes, 
membrane filtration, and activated carbon 
(Ternes and Joss 2006; Ternes et al. 2003). 
With regard to anti-infectives of agricultural 
origin, better farming practices have been pro-
posed such as erosion control to reduce runoff 
(Davis et al. 2006), increasing the maturation 
time of manure before application to enhance 
degrada  tion (De Liguoro et al. 2003), and 
the use of filters to reduce discharges by aqua-
culture operations (Smith et al. 1994). All 
of these measures should contribute to the 
reduction of urban and agricultural inputs of 
anti-infectives in the aquatic environment.
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